Drugs + Money

    Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors?

    On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive ...

    Bernie Sanders Backs #BreakThePatent Fight for Universal PrEP Access

    The fight for universal access to PrEP medication for HIV prevention was picked up ...

    Cannabis Consumers Have Power: Meet Some Pioneers of Industry Inclusivity

    In the hyper-commodifying cannabis industry, Mary Pryor of New York City is raising her ...

    Indivior Case: Don’t Throw Out the Buprenorphine With the Bathwater

    In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication ...

    US Buprenorphine Prices: A Complete List

    To accompany Alison Knopf’s April 16 article about buprenorphine in light of federal charges ...